Corcept Therapeutics (CORT) Debt Ratio (2012 - 2023)

Corcept Therapeutics (CORT) posted Debt Ratio of 0.02 for Q4 2023, down 4.42% sequentially from 0.02 in Q3 2023, and down 6.13% YoY from 0.02 in Q4 2022.

Corcept Therapeutics (CORT) Debt Ratio (2012 - 2023) Analysis & Trends

Corcept Therapeutics has reported Debt Ratio for 8 years, with the latest figure at 0.02 in Q4 2023.

  • Quarterly Debt Ratio fell 6.13% year-over-year to 0.02 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 0.02 (down 6.13% YoY) and the FY2023 annual result came in at 0.02, down 6.13% from the prior year.
  • Debt Ratio eased to 0.02 in Q4 2023 per CORT's latest filing, from 0.02 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.03 in Q2 2023 and troughed at 0.02 in Q4 2023.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.05
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.12
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.47
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 0.26
10 Corcept Therapeutics 12.37 Bn 12.07 Bn 252.09 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 0.02
Sep 30, 2023 0.02
Jun 30, 2023 0.03
Mar 31, 2023 0.02
Dec 31, 2022 0.02
Jun 30, 2017 0.05
Mar 31, 2017 0.13
Dec 31, 2016 0.21
Sep 30, 2016 0.30
Jun 30, 2016 0.39
Mar 31, 2016 0.47
Dec 31, 2015 0.53
Sep 30, 2015 0.61
Jun 30, 2015 0.65
Mar 31, 2015 0.68
Dec 31, 2014 0.98
Sep 30, 2014 0.93
Jun 30, 2014 0.79
Mar 31, 2014 0.66
Dec 31, 2013 0.56